An endovascular approach to cardioembolic stroke prevention in atrial fibrillation patients

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Device Technology

Background:

• Patient presented with chronic atrial fibrillation (AF) and a history of bleeding complications with warfarin therapy.
• High-risk factors for stroke included congestive heart failure and a prior embolic stroke.
• Warfarin therapy was not a viable long-term option due to unstable INR and bleeding episodes.

Observation:

• Percutaneous left atrial appendage transcatheter occlusion (PLAAO) was performed to occlude the left atrial appendage (LAA).
• Transesophageal echocardiography (TEE) was utilized for follow-up assessments.
• The patient was managed post-procedure with aspirin.

Findings:

• TEE at 1 and 6 months confirmed no device migration.
• No new thrombus formation related to the implant was observed.
• The patient remained free of embolic events post-procedure.

Implications:

• PLAAO is a viable and effective alternative to long-term anticoagulation for stroke prevention in high-risk AF patients intolerant to warfarin.
• This case highlights the safety and efficacy of transcatheter LAA occlusion in managing complex AF patients.
• Minimally invasive LAA occlusion offers a promising therapeutic strategy for reducing stroke risk in selected AF populations.